In compliance with the regulation 30 and 68(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed about the sad demise of Sanjivkumar Shah, Independent Director of the Company.
The above information is a part of company’s filings submitted to BSE.